Zobrazeno 1 - 10
of 168
pro vyhledávání: '"Peter F, Coccia"'
Autor:
Patricia Aoun, Geoffrey L. Uy, Steven Coutre, Suzanne L. Kirby, Bhavana Bhatnagar, Jeffrey E. Rubnitz, Arthur Liu, Amir T. Fathi, Jae H. Park, Teresa J. Bryan, Olalekan O. Oluwole, Ryan J. Mattison, Ndiya Ogba, Patrick W. Burke, Ryan Cassaday, Mark R. Litzow, Aaron C Logan, Bijal D. Shah, Stephanie A. Massaro, Matthew J. Wieduwilt, Eunice S. Wang, Kristina M. Gregory, Daniel J. DeAngelo, Nitin Jain, Anjali S. Advani, Michael Boyer, Nikolaos Papadantonakis, Patrick A. Brown, Peter F. Coccia
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:414-423
Survival outcomes for older adults with acute lymphoblastic leukemia (ALL) are poor and optimal management is challenging due to higher-risk leukemia genetics, comorbidities, and lower tolerance to intensive therapy. A critical understanding of these
Autor:
Scott C. Borinstein, Kevin C. Oeffinger, Daniel S. Wechsler, Lisa A. Gurski, Alberto S. Pappo, Steven I. Robinson, Frederick Millard, Holly Spraker-Perlman, Michael P. Link, Yousif Matloub, John A. Livingston, Robert J. Hayashi, Mary S. Huang, Tara Sanft, Shira Dinner, Rashmi Chugh, Diane Puccetti, Margaret von Mehren, Dorothy A. Shead, Alexandra Gubin, A. Lindsay Frazier, Jeanelle Folbrecht, Abby R. Rosenberg, Damon R. Reed, Nicholas D. Yeager, Kimberly Whelan, Virginia F. Borges, Peter F. Coccia, Robert E. Goldsby, Lynda K. Beaupin
Publikováno v:
Journal of the National Comprehensive Cancer Network. 16:66-97
This selection from the NCCN Guidelines for Adolescent and Young Adult (AYA) Oncology focuses on treatment and management considerations for AYA patients with cancer. Compared with older adults with cancer, AYA patients have unique needs regarding tr
Autor:
Peter F. Coccia
Publikováno v:
Journal of oncology practice. 15(5)
Autor:
Archie Bleyer, Bijal D. Shah, Lori Muffly, Brandon Hayes-Lattin, Rebecca H. Johnson, Selina M. Luger, Anjali S. Advani, Mark A. Lewis, Wendy Stock, David R. Freyer, Stuart E. Siegel, Nita L. Seibel, Daniel J. DeAngelo, Dan Douer, Jerry J. Jaboin, Peter F. Coccia
Publikováno v:
Am J Hematol
For young adults with acute lymphoblastic leukemia, pediatric-based regimens are likely to provide the following when compared to hyper-CVAD regimens: better disease control, less hospitalization time, diminished acute toxicities, decreased financial
Publikováno v:
JNCI: Journal of the National Cancer Institute. 111:633-634
Autor:
Steven G. DuBois, Archie Bleyer, Rebecca L. Olin, Peter F. Coccia, Robert E. Goldsby, Jean S. Lee
Publikováno v:
Cancer. 122:116-123
BACKGROUND The authors describe the incidence and characteristics of secondary malignant neoplasms (SMNs) in adolescent and young adult (AYA) cancer survivors compared with those in younger and older cancer survivors. METHODS Children aged ≤14 year
Publikováno v:
Cytogenetic and Genome Research. 147:31-34
Sex chromosome aneuploidies range in incidence from rather common to exceedingly rare and have a variable phenotype. We report 2 patients with sex chromosome aneuploidies who developed severe aplastic anemia requiring treatment. The first patient had
Autor:
Stefan K. Barta, Michael Boyer, Mark R. Litzow, Patrick A. Brown, Peter F. Coccia, Eunice S. Wang, Bijal D. Shah, Anjali S. Advani, Jeffrey E. Rubnitz, Lloyd E. Damon, Ndiya Ogba, Kristina M. Gregory, Ayman Saad, Rebecca B. Klisovic, Patricia Aoun, Steven Coutre, Ryan J. Mattison, John P. Greer, Arthur Liu, Gary M. Kupfer, Amir T. Fathi, Ryan Cassaday, Matthew J. Wieduwilt, Patrick W. Burke, Hagop M. Kantarjian, Jae H. Park, Geoffrey L. Uy, Daniel J. DeAngelo, Olga Frankfurt, Teresa J. Bryan
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 15(9)
The prognosis for patients with newly diagnosed acute lymphoblastic leukemia (ALL) has improved with the use of more intensive chemotherapy regimens, tyrosine kinase inhibitors, targeted agents, and allogeneic hematopoietic cell transplantation. Howe
Autor:
Peter F. Coccia, Phyllis I. Warkentin, Warren G. Sanger, James L. Wisecarver, Sachit Patel, James Harper, Bruce Geoffrey Gordon, Don W. Coulter, Alfred C. Grovas
Publikováno v:
Journal of Pediatric Hematology/Oncology
Juvenile myelomonocytic leukemia (JMML) is a rare mixed myelodysplastic and myeloproliferative clonal disorder of early childhood representing about 1% to 2% of all pediatric leukemias.1–3 Most cases present before 6 years of age, with a median age
Autor:
Peter F. Coccia, Karen Albritton
Publikováno v:
Pediatrics. 133:S104-S108
Adolescents and young adults (AYAs) have lower rates of clinical trial enrollment than younger or older patients with cancer. Multiple approaches to change policy and practice need to be used to improve this statistic. This article examines the optio